Clinical trials
Full profile accessFollow clinical development from study design and recruitment through results.
- Trial phase
- Status
- Readouts
Drug intelligence / Profile preview
Bio-tech + Omega-3 Plus is an immunonutrition regimen consisting of two distinct dietary supplements used perioperatively to improve surgical outcomes. Bio-tech is a multivitamin and essential amino acid supplement (typically containing vitamins A, C, E, B-complex, and amino acids such as L-arginine and L-lysine) designed to support metabolic demands and tissue repair. Omega-3 Plus is a fish oil-based supplement providing omega-3 fatty acids (EPA and DHA) and wheat germ oil (Vitamin E). This combination is being evaluated in clinical trials at Mansoura University to determine its influence on 90-day postoperative morbidity and infectious complications in patients undergoing radical cystectomy and bladder substitution for bladder cancer. The regimen aims to modulate the immune response and reduce systemic inflammation during the critical perioperative period.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Follow clinical development from study design and recruitment through results.
Explore development by indication, patient population, and geography.
Trace asset ownership, licensing agreements, and commercial partnerships.
Explore the patent landscape and regulatory exclusivity around an asset.
Compare development programs by target, modality, and indication.
Connect source evidence and development news to your research questions.
See how Gosset can support your research on Bio-tech + Omega-3 Plus.